Rank | Gene Set | Z-score |
---|---|---|
1 | protein maturation by protein folding (GO:0022417) | 4.82101752 |
2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.78923551 |
3 | neuron cell-cell adhesion (GO:0007158) | 4.67310096 |
4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.66516011 |
5 | synaptic vesicle exocytosis (GO:0016079) | 4.56178413 |
6 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.54484800 |
7 | proteasome assembly (GO:0043248) | 4.43305082 |
8 | regulation of mitochondrial translation (GO:0070129) | 4.40039331 |
9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.35620279 |
10 | ATP synthesis coupled proton transport (GO:0015986) | 4.35620279 |
11 | chaperone-mediated protein transport (GO:0072321) | 4.32010794 |
12 | neuronal action potential propagation (GO:0019227) | 4.17750411 |
13 | presynaptic membrane assembly (GO:0097105) | 4.09269810 |
14 | respiratory electron transport chain (GO:0022904) | 4.02686029 |
15 | presynaptic membrane organization (GO:0097090) | 4.00870286 |
16 | oxidative phosphorylation (GO:0006119) | 3.98187740 |
17 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.98141963 |
18 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.98141963 |
19 | electron transport chain (GO:0022900) | 3.93573442 |
20 | glutamate secretion (GO:0014047) | 3.87757708 |
21 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.87359479 |
22 | vocalization behavior (GO:0071625) | 3.86034636 |
23 | GDP-mannose metabolic process (GO:0019673) | 3.82612028 |
24 | axon ensheathment in central nervous system (GO:0032291) | 3.82392870 |
25 | central nervous system myelination (GO:0022010) | 3.82392870 |
26 | respiratory chain complex IV assembly (GO:0008535) | 3.77445734 |
27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.76236549 |
28 | cytochrome complex assembly (GO:0017004) | 3.73352747 |
29 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.71835722 |
30 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.71583932 |
31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.69163626 |
32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.67135894 |
33 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.63827595 |
34 | transferrin transport (GO:0033572) | 3.57995962 |
35 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.54332579 |
36 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.53085582 |
37 | protein localization to synapse (GO:0035418) | 3.51160338 |
38 | mannosylation (GO:0097502) | 3.49161960 |
39 | negative regulation of ligase activity (GO:0051352) | 3.47693877 |
40 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.47693877 |
41 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.45597591 |
42 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.45490302 |
43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.44949884 |
44 | L-phenylalanine metabolic process (GO:0006558) | 3.44949884 |
45 | neurotransmitter secretion (GO:0007269) | 3.44795293 |
46 | neurotransmitter uptake (GO:0001504) | 3.40034654 |
47 | metallo-sulfur cluster assembly (GO:0031163) | 3.37956092 |
48 | iron-sulfur cluster assembly (GO:0016226) | 3.37956092 |
49 | oxaloacetate metabolic process (GO:0006107) | 3.36902200 |
50 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.36575166 |
51 | neuron-neuron synaptic transmission (GO:0007270) | 3.34869401 |
52 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.34687237 |
53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.34687237 |
54 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.33323539 |
55 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.33323539 |
56 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.33323539 |
57 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.33161950 |
58 | protein deneddylation (GO:0000338) | 3.33008865 |
59 | trivalent inorganic cation transport (GO:0072512) | 3.32872846 |
60 | ferric iron transport (GO:0015682) | 3.32872846 |
61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30144042 |
62 | regulation of cholesterol esterification (GO:0010872) | 3.30050055 |
63 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.28532172 |
64 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.28324739 |
65 | gluconeogenesis (GO:0006094) | 3.26219215 |
66 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25990129 |
67 | cerebellar granule cell differentiation (GO:0021707) | 3.25855507 |
68 | regulation of synaptic vesicle transport (GO:1902803) | 3.22873815 |
69 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.22211462 |
70 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.22211462 |
71 | synaptic vesicle maturation (GO:0016188) | 3.20486311 |
72 | postsynaptic membrane organization (GO:0001941) | 3.18890564 |
73 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.17977636 |
74 | synaptic transmission, glutamatergic (GO:0035249) | 3.16827560 |
75 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.15669239 |
76 | branched-chain amino acid catabolic process (GO:0009083) | 3.15557562 |
77 | protein complex biogenesis (GO:0070271) | 3.15404878 |
78 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.13929058 |
79 | negative regulation of neurotransmitter transport (GO:0051589) | 3.13629005 |
80 | protein targeting to mitochondrion (GO:0006626) | 3.12970591 |
81 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.12915390 |
82 | proline biosynthetic process (GO:0006561) | 3.12358186 |
83 | monosaccharide biosynthetic process (GO:0046364) | 3.12161708 |
84 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.11765087 |
85 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11268172 |
86 | L-phenylalanine catabolic process (GO:0006559) | 3.11268172 |
87 | neuromuscular process controlling posture (GO:0050884) | 3.11023261 |
88 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.10471983 |
89 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.09683206 |
90 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.09664752 |
91 | hexose biosynthetic process (GO:0019319) | 3.09512966 |
92 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.07930301 |
93 | aerobic respiration (GO:0009060) | 3.07382107 |
94 | positive regulation of synapse assembly (GO:0051965) | 3.06615981 |
95 | cellular ketone body metabolic process (GO:0046950) | 3.05050439 |
96 | neurotransmitter transport (GO:0006836) | 3.04369446 |
97 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.04263493 |
98 | protein neddylation (GO:0045116) | 3.03876285 |
99 | gamma-aminobutyric acid transport (GO:0015812) | 3.03535813 |
100 | NADH metabolic process (GO:0006734) | 3.02731089 |
101 | regulation of cellular amine metabolic process (GO:0033238) | 3.02492685 |
102 | nuclear envelope reassembly (GO:0031468) | 3.01981594 |
103 | mitotic nuclear envelope reassembly (GO:0007084) | 3.01981594 |
104 | aldehyde catabolic process (GO:0046185) | 3.01414699 |
105 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.01382374 |
106 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.01382374 |
107 | NADH dehydrogenase complex assembly (GO:0010257) | 3.01382374 |
108 | * fatty acid elongation (GO:0030497) | 3.00989123 |
109 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.99616933 |
110 | startle response (GO:0001964) | 2.98779779 |
111 | glutamate receptor signaling pathway (GO:0007215) | 2.95390113 |
112 | positive regulation of action potential (GO:0045760) | 2.95168777 |
113 | positive regulation of ligase activity (GO:0051351) | 2.94839427 |
114 | ketone body metabolic process (GO:1902224) | 2.94838261 |
115 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.93379435 |
116 | regulation of catecholamine metabolic process (GO:0042069) | 2.92786384 |
117 | regulation of dopamine metabolic process (GO:0042053) | 2.92786384 |
118 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92541533 |
119 | regulation of cellular respiration (GO:0043457) | 2.91495554 |
120 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90942666 |
121 | substantia nigra development (GO:0021762) | 2.89767298 |
122 | adult walking behavior (GO:0007628) | 2.89102250 |
123 | regulation of neurotransmitter levels (GO:0001505) | 2.87875066 |
124 | establishment of protein localization to mitochondrion (GO:0072655) | 2.87635892 |
125 | hydrogen ion transmembrane transport (GO:1902600) | 2.87072034 |
126 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.86841989 |
127 | termination of RNA polymerase III transcription (GO:0006386) | 2.86841989 |
128 | glutathione derivative metabolic process (GO:1901685) | 2.86350702 |
129 | glutathione derivative biosynthetic process (GO:1901687) | 2.86350702 |
130 | tricarboxylic acid cycle (GO:0006099) | 2.85607147 |
131 | neuron recognition (GO:0008038) | 2.85178805 |
132 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.84706257 |
133 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.84632873 |
134 | transmission of nerve impulse (GO:0019226) | 2.84094974 |
135 | establishment of integrated proviral latency (GO:0075713) | 2.83360384 |
136 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.81047314 |
137 | long-term synaptic potentiation (GO:0060291) | 2.79818855 |
138 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.78738010 |
139 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.78708929 |
140 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.78708929 |
141 | establishment of viral latency (GO:0019043) | 2.76545439 |
142 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.75877110 |
143 | mitochondrial transport (GO:0006839) | 2.75058016 |
144 | locomotory exploration behavior (GO:0035641) | 2.74748422 |
145 | heme biosynthetic process (GO:0006783) | 2.73883136 |
146 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.73698877 |
147 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.73688410 |
148 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.72244488 |
149 | behavioral response to cocaine (GO:0048148) | 2.71786284 |
150 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.71426825 |
151 | succinate metabolic process (GO:0006105) | 2.71262625 |
152 | Golgi transport vesicle coating (GO:0048200) | 2.70760142 |
153 | COPI coating of Golgi vesicle (GO:0048205) | 2.70760142 |
154 | cullin deneddylation (GO:0010388) | 2.70759906 |
155 | protein localization to mitochondrion (GO:0070585) | 2.70610975 |
156 | ATP biosynthetic process (GO:0006754) | 2.69628922 |
157 | striatum development (GO:0021756) | 2.69395972 |
158 | pseudouridine synthesis (GO:0001522) | 2.69329099 |
159 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.68935950 |
160 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.68358310 |
161 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.68358310 |
162 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.66752057 |
163 | membrane hyperpolarization (GO:0060081) | 2.66740912 |
164 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.66398608 |
165 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.65650748 |
166 | proton transport (GO:0015992) | 2.63035942 |
167 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.62280262 |
168 | phagosome maturation (GO:0090382) | 2.62033834 |
169 | mechanosensory behavior (GO:0007638) | 2.60376955 |
170 | dopamine transport (GO:0015872) | 2.59460726 |
171 | hydrogen transport (GO:0006818) | 2.59404653 |
172 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.59122080 |
173 | regulation of glutamate secretion (GO:0014048) | 2.58602991 |
174 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.58400524 |
175 | establishment of mitochondrion localization (GO:0051654) | 2.58210000 |
176 | regulation of vesicle fusion (GO:0031338) | 2.57830491 |
177 | inner mitochondrial membrane organization (GO:0007007) | 2.57674312 |
178 | regulation of protein kinase A signaling (GO:0010738) | 2.56963656 |
179 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.55085285 |
180 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.54671721 |
181 | neuromuscular synaptic transmission (GO:0007274) | 2.54008382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.78059696 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.34567681 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.82296945 |
4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.75979005 |
5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.45998095 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.10667861 |
7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02709758 |
8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.96785591 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90966122 |
10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.87152597 |
11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.80805856 |
12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.74080939 |
13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.69991354 |
14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68969135 |
15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.61306704 |
16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.53596691 |
17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.46528338 |
18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.45462331 |
19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.42900578 |
20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42347364 |
21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.39025880 |
22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37297234 |
23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.36699773 |
24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36033233 |
25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.35997101 |
26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35736024 |
27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.33274108 |
28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.31324760 |
29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.31324760 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30714215 |
31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29151799 |
32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.19975424 |
33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19314157 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17120284 |
35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16593673 |
36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.09573852 |
37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09335144 |
38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08169579 |
39 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.05448115 |
40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.04535347 |
41 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.02861757 |
42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.01752195 |
43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.00609550 |
44 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.97356603 |
45 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97225401 |
46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95461465 |
47 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.92859685 |
48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89697578 |
49 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.89017102 |
50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.84722176 |
51 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.82995683 |
52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.82124512 |
53 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.78254058 |
54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77670582 |
55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77625991 |
56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77352963 |
57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74951578 |
58 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74832403 |
59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.73916242 |
60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73782740 |
61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.73417453 |
62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69765789 |
63 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.69527940 |
64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.69243452 |
65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65395605 |
66 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.64557341 |
67 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.63522919 |
68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62649410 |
69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59947144 |
70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58775421 |
71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58601343 |
72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56116200 |
73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55132165 |
74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.54291361 |
75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53100413 |
76 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52278138 |
77 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51514151 |
78 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51492189 |
79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49572293 |
80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.48385349 |
81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.48183850 |
82 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.47798370 |
83 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.46357224 |
84 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.45520233 |
85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.45003862 |
86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44618428 |
87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43466269 |
88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.42473108 |
89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42361584 |
90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41966343 |
91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41933209 |
92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40648815 |
93 | P68_20966046_ChIP-Seq_HELA_Human | 1.40038832 |
94 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.39084193 |
95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38560570 |
96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37913079 |
97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36722548 |
98 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36641076 |
99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35426813 |
100 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.34263632 |
101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33753248 |
102 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33227198 |
103 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32792464 |
104 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31271428 |
105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29102116 |
106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28628140 |
107 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28032204 |
108 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25615873 |
109 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25584186 |
110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25180843 |
111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25170064 |
112 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23287164 |
113 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22965089 |
114 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22776497 |
115 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21303988 |
116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20399950 |
117 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20396315 |
118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20279078 |
119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20216252 |
120 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.19658967 |
121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18531128 |
122 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16735674 |
123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16609578 |
124 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.16589586 |
125 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16244703 |
126 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16183924 |
127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.16028318 |
128 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15881612 |
129 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14855316 |
130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14824384 |
131 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14553349 |
132 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12963585 |
133 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12530934 |
134 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.12352912 |
135 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12064639 |
136 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11997586 |
137 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11978293 |
138 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11747994 |
139 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11107999 |
140 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10444184 |
141 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10283082 |
142 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10053214 |
143 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09030323 |
144 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08610603 |
145 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07763893 |
146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07506501 |
147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07500131 |
148 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06638359 |
149 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06496457 |
150 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06402170 |
151 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06374460 |
152 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05526404 |
153 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05203560 |
154 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04789770 |
155 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04531364 |
156 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04117726 |
157 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03720188 |
158 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03102319 |
159 | JUN_21703547_ChIP-Seq_K562_Human | 1.02810753 |
160 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02570995 |
161 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02179027 |
162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02015970 |
163 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01612166 |
164 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00847436 |
165 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00779253 |
166 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97869089 |
167 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97717099 |
168 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97679859 |
169 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97582985 |
170 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96435573 |
171 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95772894 |
172 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95115599 |
173 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95007285 |
174 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.94036104 |
175 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93661191 |
176 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91459387 |
177 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90042650 |
178 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.87813429 |
179 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.87771858 |
180 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.86998559 |
181 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85860745 |
182 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.83815744 |
183 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83723074 |
184 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.83047434 |
185 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.79886044 |
186 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.79886044 |
187 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79839667 |
188 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79102431 |
189 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78580768 |
190 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78374216 |
191 | AR_19668381_ChIP-Seq_PC3_Human | 0.77772343 |
192 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77501126 |
193 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.76999610 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 4.70637745 |
2 | MP0009840_abnormal_foam_cell | 4.26975107 |
3 | MP0003806_abnormal_nucleotide_metabolis | 3.74979780 |
4 | MP0004859_abnormal_synaptic_plasticity | 3.60540449 |
5 | MP0001529_abnormal_vocalization | 3.23831591 |
6 | MP0009046_muscle_twitch | 3.22790479 |
7 | MP0000372_irregular_coat_pigmentation | 3.13196764 |
8 | MP0003635_abnormal_synaptic_transmissio | 3.12304453 |
9 | MP0002064_seizures | 3.00067455 |
10 | MP0004270_analgesia | 2.94226737 |
11 | MP0005670_abnormal_white_adipose | 2.91274999 |
12 | MP0009745_abnormal_behavioral_response | 2.88543298 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.87482470 |
14 | MP0003186_abnormal_redox_activity | 2.78202259 |
15 | MP0002272_abnormal_nervous_system | 2.75787952 |
16 | MP0001968_abnormal_touch/_nociception | 2.72632918 |
17 | MP0005058_abnormal_lysosome_morphology | 2.71048802 |
18 | MP0002736_abnormal_nociception_after | 2.61768301 |
19 | MP0006276_abnormal_autonomic_nervous | 2.51235470 |
20 | MP0002063_abnormal_learning/memory/cond | 2.50704594 |
21 | MP0002572_abnormal_emotion/affect_behav | 2.49931469 |
22 | MP0003122_maternal_imprinting | 2.41624178 |
23 | MP0002734_abnormal_mechanical_nocicepti | 2.37673892 |
24 | MP0001905_abnormal_dopamine_level | 2.33495270 |
25 | MP0004142_abnormal_muscle_tone | 2.33049775 |
26 | MP0001486_abnormal_startle_reflex | 2.27594248 |
27 | MP0002735_abnormal_chemical_nociception | 2.18175493 |
28 | MP0005075_abnormal_melanosome_morpholog | 2.11974605 |
29 | MP0003693_abnormal_embryo_hatching | 2.09862564 |
30 | MP0008875_abnormal_xenobiotic_pharmacok | 2.08232220 |
31 | MP0002837_dystrophic_cardiac_calcinosis | 2.06886859 |
32 | MP0001440_abnormal_grooming_behavior | 2.04366107 |
33 | MP0005423_abnormal_somatic_nervous | 2.01386499 |
34 | MP0008058_abnormal_DNA_repair | 1.98976791 |
35 | MP0002067_abnormal_sensory_capabilities | 1.96416006 |
36 | MP0005646_abnormal_pituitary_gland | 1.95316298 |
37 | MP0001764_abnormal_homeostasis | 1.93787983 |
38 | MP0002822_catalepsy | 1.93570731 |
39 | MP0001501_abnormal_sleep_pattern | 1.90336680 |
40 | MP0002938_white_spotting | 1.87593707 |
41 | MP0001970_abnormal_pain_threshold | 1.82903077 |
42 | MP0001984_abnormal_olfaction | 1.78431893 |
43 | MP0000751_myopathy | 1.78304574 |
44 | MP0002733_abnormal_thermal_nociception | 1.78173121 |
45 | MP0004924_abnormal_behavior | 1.77076598 |
46 | MP0005386_behavior/neurological_phenoty | 1.77076598 |
47 | MP0002139_abnormal_hepatobiliary_system | 1.71982818 |
48 | MP0003329_amyloid_beta_deposits | 1.71402623 |
49 | MP0003786_premature_aging | 1.69190739 |
50 | MP0003123_paternal_imprinting | 1.68037495 |
51 | MP0000778_abnormal_nervous_system | 1.61951063 |
52 | MP0010329_abnormal_lipoprotein_level | 1.60666731 |
53 | MP0000920_abnormal_myelination | 1.60481969 |
54 | MP0008569_lethality_at_weaning | 1.59875770 |
55 | MP0005332_abnormal_amino_acid | 1.57660412 |
56 | MP0002557_abnormal_social/conspecific_i | 1.53326904 |
57 | MP0002184_abnormal_innervation | 1.51334954 |
58 | MP0005408_hypopigmentation | 1.46458902 |
59 | MP0005636_abnormal_mineral_homeostasis | 1.46132733 |
60 | MP0003195_calcinosis | 1.46050593 |
61 | MP0003718_maternal_effect | 1.43199705 |
62 | MP0003136_yellow_coat_color | 1.42829768 |
63 | MP0005645_abnormal_hypothalamus_physiol | 1.41491936 |
64 | MP0010030_abnormal_orbit_morphology | 1.37387385 |
65 | MP0003787_abnormal_imprinting | 1.36726036 |
66 | MP0005365_abnormal_bile_salt | 1.36535101 |
67 | MP0002066_abnormal_motor_capabilities/c | 1.36489238 |
68 | MP0005330_cardiomyopathy | 1.35502780 |
69 | MP0010094_abnormal_chromosome_stability | 1.35409704 |
70 | MP0002882_abnormal_neuron_morphology | 1.33413832 |
71 | MP0000955_abnormal_spinal_cord | 1.32189976 |
72 | MP0003011_delayed_dark_adaptation | 1.28720217 |
73 | MP0000015_abnormal_ear_pigmentation | 1.28628158 |
74 | MP0002229_neurodegeneration | 1.27673242 |
75 | MP0005551_abnormal_eye_electrophysiolog | 1.26940957 |
76 | MP0003111_abnormal_nucleus_morphology | 1.22223860 |
77 | MP0003646_muscle_fatigue | 1.22010287 |
78 | MP0001502_abnormal_circadian_rhythm | 1.18770232 |
79 | MP0005501_abnormal_skin_physiology | 1.17199486 |
80 | MP0005171_absent_coat_pigmentation | 1.16884770 |
81 | MP0000003_abnormal_adipose_tissue | 1.15938425 |
82 | MP0004811_abnormal_neuron_physiology | 1.15357477 |
83 | MP0004742_abnormal_vestibular_system | 1.14177027 |
84 | MP0009697_abnormal_copulation | 1.13677728 |
85 | MP0001188_hyperpigmentation | 1.13172010 |
86 | MP0004215_abnormal_myocardial_fiber | 1.12521371 |
87 | MP0010234_abnormal_vibrissa_follicle | 1.11593421 |
88 | MP0009780_abnormal_chondrocyte_physiolo | 1.11425720 |
89 | MP0005410_abnormal_fertilization | 1.11174684 |
90 | MP0002090_abnormal_vision | 1.10772763 |
91 | MP0004957_abnormal_blastocyst_morpholog | 1.10583994 |
92 | MP0000358_abnormal_cell_content/ | 1.10471197 |
93 | MP0002796_impaired_skin_barrier | 1.10384402 |
94 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09438638 |
95 | MP0003634_abnormal_glial_cell | 1.09047852 |
96 | MP0004858_abnormal_nervous_system | 1.08900330 |
97 | MP0004145_abnormal_muscle_electrophysio | 1.07484926 |
98 | MP0001346_abnormal_lacrimal_gland | 1.07431619 |
99 | MP0003690_abnormal_glial_cell | 1.07339998 |
100 | MP0002876_abnormal_thyroid_physiology | 1.06554835 |
101 | MP0004885_abnormal_endolymph | 1.05113705 |
102 | MP0003631_nervous_system_phenotype | 1.04985760 |
103 | MP0004019_abnormal_vitamin_homeostasis | 1.04469383 |
104 | MP0008872_abnormal_physiological_respon | 1.04207506 |
105 | MP0000749_muscle_degeneration | 1.04117162 |
106 | MP0003633_abnormal_nervous_system | 1.03858396 |
107 | MP0004036_abnormal_muscle_relaxation | 1.03441146 |
108 | MP0004043_abnormal_pH_regulation | 1.02786663 |
109 | MP0002118_abnormal_lipid_homeostasis | 1.02036459 |
110 | MP0002095_abnormal_skin_pigmentation | 1.01662260 |
111 | MP0006035_abnormal_mitochondrial_morpho | 1.01211980 |
112 | MP0006036_abnormal_mitochondrial_physio | 1.01143786 |
113 | MP0001986_abnormal_taste_sensitivity | 1.00122527 |
114 | MP0003137_abnormal_impulse_conducting | 0.97448806 |
115 | MP0000639_abnormal_adrenal_gland | 0.97058084 |
116 | MP0004381_abnormal_hair_follicle | 0.96760078 |
117 | MP0001963_abnormal_hearing_physiology | 0.96256833 |
118 | MP0009643_abnormal_urine_homeostasis | 0.96228446 |
119 | MP0004085_abnormal_heartbeat | 0.96093550 |
120 | MP0002163_abnormal_gland_morphology | 0.96019197 |
121 | MP0003632_abnormal_nervous_system | 0.94582532 |
122 | MP0003879_abnormal_hair_cell | 0.93015901 |
123 | MP0000647_abnormal_sebaceous_gland | 0.92605619 |
124 | MP0008932_abnormal_embryonic_tissue | 0.92305387 |
125 | MP0002752_abnormal_somatic_nervous | 0.92097056 |
126 | MP0005379_endocrine/exocrine_gland_phen | 0.91559213 |
127 | MP0005165_increased_susceptibility_to | 0.91080361 |
128 | MP0008007_abnormal_cellular_replicative | 0.91051886 |
129 | MP0003638_abnormal_response/metabolism_ | 0.91019120 |
130 | MP0005083_abnormal_biliary_tract | 0.90958941 |
131 | MP0001485_abnormal_pinna_reflex | 0.90919266 |
132 | MP0003075_altered_response_to | 0.90144679 |
133 | MP0005451_abnormal_body_composition | 0.89191770 |
134 | MP0005394_taste/olfaction_phenotype | 0.88146564 |
135 | MP0005499_abnormal_olfactory_system | 0.88146564 |
136 | MP0002909_abnormal_adrenal_gland | 0.85507836 |
137 | MP0000579_abnormal_nail_morphology | 0.85495926 |
138 | MP0002152_abnormal_brain_morphology | 0.85182427 |
139 | MP0005452_abnormal_adipose_tissue | 0.84887738 |
140 | MP0000013_abnormal_adipose_tissue | 0.84778168 |
141 | MP0003183_abnormal_peptide_metabolism | 0.83986118 |
142 | MP0004147_increased_porphyrin_level | 0.81755008 |
143 | MP0002069_abnormal_eating/drinking_beha | 0.81167680 |
144 | MP0001664_abnormal_digestion | 0.79941554 |
145 | MP0002970_abnormal_white_adipose | 0.79092937 |
146 | MP0010771_integument_phenotype | 0.78261750 |
147 | MP0000747_muscle_weakness | 0.78025010 |
148 | MP0000631_abnormal_neuroendocrine_gland | 0.75808168 |
149 | MP0004233_abnormal_muscle_weight | 0.75101367 |
150 | MP0005535_abnormal_body_temperature | 0.74487968 |
151 | MP0000566_synostosis | 0.74296823 |
152 | MP0002751_abnormal_autonomic_nervous | 0.73909707 |
153 | MP0005367_renal/urinary_system_phenotyp | 0.73871047 |
154 | MP0000516_abnormal_urinary_system | 0.73871047 |
155 | MP0003878_abnormal_ear_physiology | 0.72537608 |
156 | MP0005377_hearing/vestibular/ear_phenot | 0.72537608 |
157 | MP0005253_abnormal_eye_physiology | 0.72065067 |
158 | MP0003121_genomic_imprinting | 0.71991067 |
159 | MP0005375_adipose_tissue_phenotype | 0.71744831 |
160 | MP0010386_abnormal_urinary_bladder | 0.71536564 |
161 | MP0006072_abnormal_retinal_apoptosis | 0.70553179 |
162 | MP0002332_abnormal_exercise_endurance | 0.70510966 |
163 | MP0002638_abnormal_pupillary_reflex | 0.70197660 |
164 | MP0005409_darkened_coat_color | 0.68923935 |
165 | MP0008877_abnormal_DNA_methylation | 0.67160013 |
166 | MP0002653_abnormal_ependyma_morphology | 0.66512613 |
167 | MP0000026_abnormal_inner_ear | 0.63350766 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.44105362 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 5.07683220 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.81260119 |
4 | Pheochromocytoma (HP:0002666) | 4.66281172 |
5 | Myokymia (HP:0002411) | 4.50469250 |
6 | Mitochondrial inheritance (HP:0001427) | 4.33899594 |
7 | Neuroendocrine neoplasm (HP:0100634) | 4.33761013 |
8 | Atonic seizures (HP:0010819) | 4.27421333 |
9 | Progressive macrocephaly (HP:0004481) | 4.22983790 |
10 | Acute encephalopathy (HP:0006846) | 4.18088588 |
11 | Hepatocellular necrosis (HP:0001404) | 4.11502009 |
12 | Epileptic encephalopathy (HP:0200134) | 4.02481232 |
13 | Abnormality of glycolysis (HP:0004366) | 3.98841018 |
14 | Increased serum pyruvate (HP:0003542) | 3.98841018 |
15 | Type I transferrin isoform profile (HP:0003642) | 3.79260018 |
16 | Increased CSF lactate (HP:0002490) | 3.73751162 |
17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.64668418 |
18 | Focal seizures (HP:0007359) | 3.44882542 |
19 | Hepatic necrosis (HP:0002605) | 3.33408116 |
20 | Hyperventilation (HP:0002883) | 3.32842629 |
21 | Leukodystrophy (HP:0002415) | 3.24896228 |
22 | Febrile seizures (HP:0002373) | 3.21644107 |
23 | Abnormal hair whorl (HP:0010721) | 3.21000098 |
24 | Abnormal protein glycosylation (HP:0012346) | 3.10774515 |
25 | Abnormal glycosylation (HP:0012345) | 3.10774515 |
26 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.10774515 |
27 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.10774515 |
28 | Absence seizures (HP:0002121) | 3.02886693 |
29 | Increased muscle lipid content (HP:0009058) | 2.96593317 |
30 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.91306722 |
31 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.89192578 |
32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.89192578 |
33 | Progressive cerebellar ataxia (HP:0002073) | 2.85650513 |
34 | Dialeptic seizures (HP:0011146) | 2.84911700 |
35 | Limb dystonia (HP:0002451) | 2.82133114 |
36 | Cerebral edema (HP:0002181) | 2.79164176 |
37 | Hypokinesia (HP:0002375) | 2.74764340 |
38 | Gait imbalance (HP:0002141) | 2.74550123 |
39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.74490342 |
40 | Dicarboxylic aciduria (HP:0003215) | 2.74490342 |
41 | Polyphagia (HP:0002591) | 2.74197810 |
42 | Optic disc pallor (HP:0000543) | 2.73094955 |
43 | Visual hallucinations (HP:0002367) | 2.73016346 |
44 | Poor suck (HP:0002033) | 2.70258470 |
45 | Respiratory failure (HP:0002878) | 2.66231980 |
46 | Generalized tonic-clonic seizures (HP:0002069) | 2.65538620 |
47 | Testicular atrophy (HP:0000029) | 2.65159719 |
48 | Rhabdomyolysis (HP:0003201) | 2.64296864 |
49 | Lactic acidosis (HP:0003128) | 2.58866779 |
50 | Abnormality of the corticospinal tract (HP:0002492) | 2.57697613 |
51 | Congenital primary aphakia (HP:0007707) | 2.56682794 |
52 | Medial flaring of the eyebrow (HP:0010747) | 2.52879414 |
53 | Abnormal eating behavior (HP:0100738) | 2.47078643 |
54 | Opisthotonus (HP:0002179) | 2.46779191 |
55 | Sparse eyelashes (HP:0000653) | 2.44245443 |
56 | Nephrogenic diabetes insipidus (HP:0009806) | 2.43747113 |
57 | Failure to thrive in infancy (HP:0001531) | 2.43422325 |
58 | Methylmalonic aciduria (HP:0012120) | 2.43127419 |
59 | Sensory axonal neuropathy (HP:0003390) | 2.42470139 |
60 | Tongue fasciculations (HP:0001308) | 2.41614684 |
61 | Ankle clonus (HP:0011448) | 2.41061003 |
62 | Anxiety (HP:0000739) | 2.40958862 |
63 | Vaginal atresia (HP:0000148) | 2.40401811 |
64 | Reduced antithrombin III activity (HP:0001976) | 2.40317535 |
65 | Broad-based gait (HP:0002136) | 2.38615520 |
66 | Lethargy (HP:0001254) | 2.37941185 |
67 | Genital tract atresia (HP:0001827) | 2.37283603 |
68 | Cerebral hypomyelination (HP:0006808) | 2.34814802 |
69 | Exercise intolerance (HP:0003546) | 2.34684664 |
70 | Renal Fanconi syndrome (HP:0001994) | 2.31957362 |
71 | Abnormality of alanine metabolism (HP:0010916) | 2.31893816 |
72 | Hyperalaninemia (HP:0003348) | 2.31893816 |
73 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.31893816 |
74 | Myoglobinuria (HP:0002913) | 2.30773057 |
75 | Hypothermia (HP:0002045) | 2.29456702 |
76 | Cholecystitis (HP:0001082) | 2.29189575 |
77 | Abnormal gallbladder physiology (HP:0012438) | 2.29189575 |
78 | Oligomenorrhea (HP:0000876) | 2.28954192 |
79 | Hypoglycemic coma (HP:0001325) | 2.28626729 |
80 | Microvesicular hepatic steatosis (HP:0001414) | 2.26852997 |
81 | Dysmetria (HP:0001310) | 2.26521770 |
82 | Myopathic facies (HP:0002058) | 2.26431390 |
83 | Neurofibrillary tangles (HP:0002185) | 2.25467440 |
84 | Ragged-red muscle fibers (HP:0003200) | 2.24725568 |
85 | Spastic gait (HP:0002064) | 2.22286057 |
86 | Scanning speech (HP:0002168) | 2.22174314 |
87 | Prolonged neonatal jaundice (HP:0006579) | 2.21687225 |
88 | Microretrognathia (HP:0000308) | 2.20248931 |
89 | Supranuclear gaze palsy (HP:0000605) | 2.19525522 |
90 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.16802057 |
91 | Increased serum lactate (HP:0002151) | 2.16453708 |
92 | Emotional lability (HP:0000712) | 2.16040204 |
93 | Spastic paraparesis (HP:0002313) | 2.14704343 |
94 | Degeneration of anterior horn cells (HP:0002398) | 2.13651774 |
95 | Abnormality of the anterior horn cell (HP:0006802) | 2.13651774 |
96 | Progressive microcephaly (HP:0000253) | 2.13222067 |
97 | Patchy hypopigmentation of hair (HP:0011365) | 2.12062599 |
98 | Cerebral palsy (HP:0100021) | 2.11748094 |
99 | Increased hepatocellular lipid droplets (HP:0006565) | 2.11543761 |
100 | Specific learning disability (HP:0001328) | 2.07985253 |
101 | Ketoacidosis (HP:0001993) | 2.07822165 |
102 | Epileptiform EEG discharges (HP:0011182) | 2.05404321 |
103 | X-linked dominant inheritance (HP:0001423) | 2.04943371 |
104 | CNS hypomyelination (HP:0003429) | 2.03437570 |
105 | Truncal ataxia (HP:0002078) | 2.02988930 |
106 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.02718265 |
107 | 3-Methylglutaconic aciduria (HP:0003535) | 2.01402630 |
108 | Dysdiadochokinesis (HP:0002075) | 2.00056957 |
109 | Parakeratosis (HP:0001036) | 2.00019553 |
110 | Abnormal gallbladder morphology (HP:0012437) | 2.00000877 |
111 | Gaze-evoked nystagmus (HP:0000640) | 1.99592580 |
112 | Exercise-induced muscle cramps (HP:0003710) | 1.99373376 |
113 | Large for gestational age (HP:0001520) | 1.99169966 |
114 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98150612 |
115 | Vacuolated lymphocytes (HP:0001922) | 1.97878705 |
116 | Methylmalonic acidemia (HP:0002912) | 1.97428787 |
117 | CNS demyelination (HP:0007305) | 1.93945346 |
118 | Gout (HP:0001997) | 1.93718405 |
119 | Hyperammonemia (HP:0001987) | 1.92081311 |
120 | Progressive inability to walk (HP:0002505) | 1.90904215 |
121 | Action tremor (HP:0002345) | 1.90571487 |
122 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89891226 |
123 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.89361958 |
124 | Ketosis (HP:0001946) | 1.88862304 |
125 | Narrow nasal bridge (HP:0000446) | 1.88658522 |
126 | Cholelithiasis (HP:0001081) | 1.87908225 |
127 | Cerebral hemorrhage (HP:0001342) | 1.87900616 |
128 | Gliosis (HP:0002171) | 1.87436105 |
129 | Abnormal pupillary function (HP:0007686) | 1.87430003 |
130 | Hypoglycemic seizures (HP:0002173) | 1.86698376 |
131 | Esotropia (HP:0000565) | 1.86174963 |
132 | Psychosis (HP:0000709) | 1.85868214 |
133 | Abnormality of the labia minora (HP:0012880) | 1.85075361 |
134 | Poor coordination (HP:0002370) | 1.84767481 |
135 | Exercise-induced myalgia (HP:0003738) | 1.84140917 |
136 | Lipid accumulation in hepatocytes (HP:0006561) | 1.83998506 |
137 | Delayed CNS myelination (HP:0002188) | 1.83870022 |
138 | Muscle fibrillation (HP:0010546) | 1.83058299 |
139 | Fasciculations (HP:0002380) | 1.82831435 |
140 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.81474494 |
141 | Hypsarrhythmia (HP:0002521) | 1.81335623 |
142 | Poor speech (HP:0002465) | 1.81060511 |
143 | Respiratory difficulties (HP:0002880) | 1.78032283 |
144 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.76790148 |
145 | Unsteady gait (HP:0002317) | 1.76718251 |
146 | Generalized aminoaciduria (HP:0002909) | 1.76628899 |
147 | White forelock (HP:0002211) | 1.76615294 |
148 | Termporal pattern (HP:0011008) | 1.76572846 |
149 | Insidious onset (HP:0003587) | 1.76572846 |
150 | Akinesia (HP:0002304) | 1.76030899 |
151 | Delusions (HP:0000746) | 1.75903595 |
152 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.75820289 |
153 | Abnormality of magnesium homeostasis (HP:0004921) | 1.74248982 |
154 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.73499923 |
155 | Distal lower limb muscle weakness (HP:0009053) | 1.73435508 |
156 | Fetal akinesia sequence (HP:0001989) | 1.73209108 |
157 | Progressive muscle weakness (HP:0003323) | 1.72885609 |
158 | Calf muscle hypertrophy (HP:0008981) | 1.72424077 |
159 | Depression (HP:0000716) | 1.71533529 |
160 | Pancytopenia (HP:0001876) | 1.69571001 |
161 | Cerebral inclusion bodies (HP:0100314) | 1.69339788 |
162 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.68592950 |
163 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.68310387 |
164 | Abnormality of the gallbladder (HP:0005264) | 1.65774453 |
165 | Vomiting (HP:0002013) | 1.65141618 |
166 | Xanthomatosis (HP:0000991) | 1.63800026 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 5.57550100 |
2 | CASK | 4.47378956 |
3 | MAP3K12 | 3.89295724 |
4 | NME2 | 3.88599275 |
5 | TESK2 | 3.81075252 |
6 | BUB1 | 3.46622464 |
7 | TESK1 | 3.20530874 |
8 | CDK19 | 3.01113472 |
9 | NTRK3 | 2.99687827 |
10 | OXSR1 | 2.71494371 |
11 | MAP2K7 | 2.52783864 |
12 | STK39 | 2.43653868 |
13 | PIM2 | 2.43585003 |
14 | MAP3K4 | 2.41809372 |
15 | EPHA2 | 2.34637547 |
16 | MAPKAPK3 | 2.27927682 |
17 | PBK | 2.17599853 |
18 | PRPF4B | 2.12953071 |
19 | MINK1 | 1.94717364 |
20 | EPHA4 | 1.93422626 |
21 | BCR | 1.81795214 |
22 | MARK1 | 1.76847511 |
23 | NME1 | 1.73108421 |
24 | TNIK | 1.70850249 |
25 | KDR | 1.65799119 |
26 | MAP2K4 | 1.62998787 |
27 | PLK2 | 1.62575899 |
28 | EIF2AK1 | 1.58622708 |
29 | MYLK | 1.55188500 |
30 | NTRK2 | 1.54671910 |
31 | LIMK1 | 1.49770974 |
32 | UHMK1 | 1.49676317 |
33 | MAPK13 | 1.48594580 |
34 | ARAF | 1.47410767 |
35 | SIK3 | 1.44935143 |
36 | PHKG2 | 1.43482953 |
37 | PHKG1 | 1.43482953 |
38 | BRSK1 | 1.42519555 |
39 | TSSK6 | 1.41641254 |
40 | CCNB1 | 1.40257451 |
41 | SGK223 | 1.39674305 |
42 | SGK494 | 1.39674305 |
43 | VRK1 | 1.37718803 |
44 | WNK4 | 1.35605592 |
45 | AKT3 | 1.34120973 |
46 | DAPK1 | 1.28895204 |
47 | CAMK2B | 1.28732857 |
48 | ABL2 | 1.28628357 |
49 | MAPKAPK5 | 1.28315309 |
50 | MAP3K11 | 1.27673312 |
51 | CAMK2A | 1.21282578 |
52 | MAP3K9 | 1.20241741 |
53 | PRKCG | 1.18914528 |
54 | GRK7 | 1.17308212 |
55 | GRK5 | 1.17199797 |
56 | MST1R | 1.16131564 |
57 | DAPK2 | 1.15896033 |
58 | PNCK | 1.11537233 |
59 | CDK5 | 1.07926759 |
60 | CAMK2D | 1.05967376 |
61 | CSNK1G3 | 1.05683605 |
62 | ERN1 | 1.02619881 |
63 | CDK18 | 1.01690384 |
64 | SMG1 | 1.01019360 |
65 | MAP4K2 | 0.99474469 |
66 | STK16 | 0.98852793 |
67 | LMTK2 | 0.97966727 |
68 | TRIM28 | 0.97960077 |
69 | CDK14 | 0.96622175 |
70 | MUSK | 0.95983823 |
71 | ADRBK2 | 0.95764607 |
72 | WNK1 | 0.94820945 |
73 | ROCK2 | 0.94627921 |
74 | PAK6 | 0.94266452 |
75 | CDK15 | 0.93306086 |
76 | CAMK2G | 0.93061108 |
77 | BRAF | 0.92122773 |
78 | CSNK1G2 | 0.91968549 |
79 | NTRK1 | 0.91749529 |
80 | PKN1 | 0.91012497 |
81 | PDK3 | 0.89665703 |
82 | PDK4 | 0.89665703 |
83 | MAP2K6 | 0.88727875 |
84 | PRKCI | 0.86846568 |
85 | BMPR1B | 0.86788523 |
86 | PRKCE | 0.86302699 |
87 | WEE1 | 0.86301527 |
88 | PAK4 | 0.85720736 |
89 | SCYL2 | 0.82989141 |
90 | CDK11A | 0.82415708 |
91 | PRKD3 | 0.81672042 |
92 | OBSCN | 0.80145551 |
93 | ADRBK1 | 0.77829746 |
94 | SGK2 | 0.77206804 |
95 | PLK3 | 0.75461240 |
96 | WNK3 | 0.71483070 |
97 | NEK6 | 0.71437176 |
98 | PAK1 | 0.70208585 |
99 | AURKA | 0.69814690 |
100 | TTK | 0.69798789 |
101 | NUAK1 | 0.67438789 |
102 | PLK1 | 0.66845949 |
103 | IRAK3 | 0.66084502 |
104 | SRPK1 | 0.65738749 |
105 | NEK1 | 0.65439155 |
106 | KSR1 | 0.64720737 |
107 | PINK1 | 0.63998926 |
108 | CAMKK2 | 0.63837814 |
109 | PAK3 | 0.62631327 |
110 | MAPK11 | 0.61826289 |
111 | LRRK2 | 0.59325475 |
112 | AKT2 | 0.58370984 |
113 | TAOK2 | 0.58181881 |
114 | ZAK | 0.57983617 |
115 | ATR | 0.57642458 |
116 | DAPK3 | 0.57113927 |
117 | ILK | 0.55901298 |
118 | MAP3K3 | 0.54275986 |
119 | TNK2 | 0.54046639 |
120 | CSNK1G1 | 0.53597123 |
121 | PRKACA | 0.52800804 |
122 | SIK1 | 0.52620013 |
123 | DYRK2 | 0.51131515 |
124 | PDK2 | 0.50417221 |
125 | CAMK1 | 0.45890029 |
126 | BCKDK | 0.45765569 |
127 | CSNK1A1L | 0.45226205 |
128 | PRKCH | 0.45001574 |
129 | DYRK1A | 0.44329174 |
130 | RPS6KB2 | 0.42306224 |
131 | CDK7 | 0.42282218 |
132 | CSNK2A1 | 0.42063512 |
133 | BMPR2 | 0.41810554 |
134 | PRKACB | 0.41286764 |
135 | PTK2B | 0.41270631 |
136 | CDK8 | 0.41225814 |
137 | AURKB | 0.40688193 |
138 | PRKG1 | 0.40584775 |
139 | FES | 0.39377458 |
140 | STK10 | 0.38610616 |
141 | ERBB4 | 0.37680854 |
142 | CSNK2A2 | 0.36818607 |
143 | FGFR2 | 0.36516971 |
144 | MST4 | 0.36109250 |
145 | PRKCA | 0.34586974 |
146 | CSNK1A1 | 0.33489057 |
147 | PDPK1 | 0.32558838 |
148 | SGK1 | 0.32024051 |
149 | ROCK1 | 0.31761388 |
150 | SGK3 | 0.31409754 |
151 | CHEK2 | 0.29524070 |
152 | FER | 0.29261030 |
153 | CDC7 | 0.28276109 |
154 | EIF2AK2 | 0.24995775 |
155 | TBK1 | 0.24806567 |
156 | STK4 | 0.24327004 |
157 | RPS6KA5 | 0.22424005 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.30315453 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.45753071 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.40781624 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.18461849 |
5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.17088843 |
6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.68041034 |
7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.46623016 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.44954241 |
9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.26740469 |
10 | DNA replication_Homo sapiens_hsa03030 | 2.23919066 |
11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.22352084 |
12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18209456 |
13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.14371237 |
14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.11300161 |
15 | Sulfur relay system_Homo sapiens_hsa04122 | 2.07993286 |
16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.01897352 |
17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.93489594 |
18 | Base excision repair_Homo sapiens_hsa03410 | 1.90824102 |
19 | * Fatty acid elongation_Homo sapiens_hsa00062 | 1.87867117 |
20 | RNA polymerase_Homo sapiens_hsa03020 | 1.84441207 |
21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.82276677 |
22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.76562591 |
23 | Morphine addiction_Homo sapiens_hsa05032 | 1.75559539 |
24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.73359775 |
25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71103223 |
26 | Mismatch repair_Homo sapiens_hsa03430 | 1.70895680 |
27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.65237172 |
28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62966432 |
29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.58134156 |
30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55691813 |
31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.53881709 |
32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50162659 |
33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49658752 |
34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.49542592 |
35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46567880 |
36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46516436 |
37 | Taste transduction_Homo sapiens_hsa04742 | 1.45751469 |
38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45736301 |
39 | Ribosome_Homo sapiens_hsa03010 | 1.42540004 |
40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30379423 |
41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.27412442 |
42 | Homologous recombination_Homo sapiens_hsa03440 | 1.27113725 |
43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27049966 |
44 | * Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24807522 |
45 | Long-term potentiation_Homo sapiens_hsa04720 | 1.23783962 |
46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23762854 |
47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.23124176 |
48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21954309 |
49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20834305 |
50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19238380 |
51 | Insulin secretion_Homo sapiens_hsa04911 | 1.18344814 |
52 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18201360 |
53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17149217 |
54 | Long-term depression_Homo sapiens_hsa04730 | 1.14940422 |
55 | Salivary secretion_Homo sapiens_hsa04970 | 1.14551775 |
56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.08788357 |
57 | Proteasome_Homo sapiens_hsa03050 | 1.07847348 |
58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.06525617 |
59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.05855645 |
60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05014216 |
61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04704491 |
62 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02698706 |
63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.00426062 |
64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00413024 |
65 | Purine metabolism_Homo sapiens_hsa00230 | 0.98871776 |
66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97661030 |
67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94664233 |
68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93310497 |
69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93112605 |
70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91079016 |
71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90993744 |
72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90009968 |
73 | Renin secretion_Homo sapiens_hsa04924 | 0.87629433 |
74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86908184 |
75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85032370 |
76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84010760 |
77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83229991 |
78 | Protein export_Homo sapiens_hsa03060 | 0.82873405 |
79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82603430 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79696739 |
81 | Phototransduction_Homo sapiens_hsa04744 | 0.79436109 |
82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79315130 |
83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78426213 |
84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78217723 |
85 | Axon guidance_Homo sapiens_hsa04360 | 0.76844454 |
86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74962235 |
87 | Spliceosome_Homo sapiens_hsa03040 | 0.73448687 |
88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72899936 |
89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72037459 |
90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71156791 |
91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70744047 |
92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70434849 |
93 | Phagosome_Homo sapiens_hsa04145 | 0.70355418 |
94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67181289 |
95 | Gap junction_Homo sapiens_hsa04540 | 0.66716472 |
96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64994475 |
97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64865651 |
98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64163853 |
99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63993867 |
100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63676187 |
101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61498432 |
102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61441314 |
103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60736989 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60360341 |
105 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60342633 |
106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57175284 |
107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56426858 |
108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55785718 |
109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55443719 |
110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51334646 |
111 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50508189 |
112 | Lysosome_Homo sapiens_hsa04142 | 0.49937645 |
113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47266767 |
114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47251129 |
115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47221492 |
116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47021591 |
117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47014326 |
118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46868363 |
119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46276310 |
120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44139904 |
121 | Peroxisome_Homo sapiens_hsa04146 | 0.43471875 |
122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39806919 |
123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39713081 |
124 | RNA transport_Homo sapiens_hsa03013 | 0.36837282 |
125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32053508 |
126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31411971 |
127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31271087 |
128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31049491 |
129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31032473 |
130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30420105 |
131 | Melanogenesis_Homo sapiens_hsa04916 | 0.29079578 |
132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28780125 |
133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27651413 |
134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27610224 |
135 | RNA degradation_Homo sapiens_hsa03018 | 0.27479337 |
136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27442260 |
137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26419457 |
138 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26240887 |
139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26177651 |
140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25872114 |
141 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24949603 |
142 | Alcoholism_Homo sapiens_hsa05034 | 0.24806989 |
143 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23942428 |
144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23418027 |
145 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.22555540 |
146 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22314631 |
147 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.21820601 |
148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21453323 |
149 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21220663 |
150 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20743776 |
151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20611360 |
152 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19687995 |
153 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19603021 |